diabetes glp-1 vs sglt2 inhibitors and receptor agonists: a sound combination GLP-1RAs and SGLT2 Inhibitors Show

If you already have diabetic retinopathy, macular edema, or other diabetes-related eye problems, your risk for complications increases

10.1080/19490976.2023.2274124 109 WangW.MeiA.QianH.LiD.XuH.ChenJ.et al (2023b)

We recently published detailed insights on two next-generation GLP-1 medications, providing valuable information for individuals seeking the latest updates in the field: Mazdutide: A Next-Gen GLP-1 Therapy Learn about this novel GLP-1/GIP dual agonist and its potential benefits: www.patchmd.com/mazdutide.html

Some patients may successfully transition to lower maintenance doses, while others may benefit from combining pharmacotherapy with intensive lifestyle interventions